Explore >> Select a destination

You are here

 www.fda.gov
FDA Authorizes Updated Novavax COVID-19 Vaccine Formulated to Better Protect Against Currently Circulating Variants | FDA
| | news.mcmaster.ca
Researchers to begin human trials for promising new inhaled COVID-19 vaccines designed to combat variants of concern - McMaster News
1.8 parsecs away

Travel
| | Vaccines developed at McMaster target the lungs first. [...]Read More...
| | www.cancer.gov
How mRNA Vaccines Might Help Treat Cancer - NCI
3.1 parsecs away

Travel
| | The success of COVID-19 mRNA vaccines could accelerate research on mRNA vaccines to treat cancer. Read about the progress of mRNA cancer vaccines.
| | www.someweekendreading.blog
US FDA Grants Emergency Use Authorization for Bivalent Classic/Omicron COVID-19 Vaccines - Some Weekend Reading - Occasional ...
2.4 parsecs away

Travel
| | Today the FDA granted Emergency Use Authorization (EUA) to both Pfizer and Moderna's bivalent COVID-19 vaccines for classic and Omicron/BA.4/5 variants.
| | president.ubc.ca
Letter to the Community re: Budget - Office of the President
23.8 parsecs away

Travel
| With the 2014-15 UBC budget now approved by the Board of Governors, I wanted to provide my annual update on the financial context and outlook of the University.